Indication
Acute myeloid leukemia
Acute myeloid leukemia is an aggressive hematologic malignancy characterized by the clonal proliferation and accumulation of immature myeloid precursors, or myeloblasts, within the bone marrow and peripheral blood. Read more about Acute myeloid leukemia
113 drugs 65 manufacturers
Drugs that treat it
Common Acute myeloid leukemia therapies.
DOXORUBICIN HCL
DOXORUBICIN HCL
CYCLOPHOSPHAMIDE
CYCLOPHOSPHAMIDE
CYCLOPHOSPHAMIDE
CYCLOPHOSPHAMIDE
CYCLOPHOSPHAMIDE
DOXORUBICIN HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAcute myeloid leukemia is an aggressive hematologic malignancy characterized by the clonal proliferation and accumulation of immature myeloid precursors, or myeloblasts, within the bone marrow and peripheral blood.
This rapid malignant expansion primarily affects the hematopoietic system in adults, although it can manifest across all age groups.
Pathophysiologically, the infiltration of leukemic blasts disrupts normal hematopoiesis, leading to severe bone marrow failure marked by cytopenias.
Consequently, patients frequently present with debilitating fatigue due to anemia, life-threatening infections secondary to neutropenia, and spontaneous bruising or hemorrhage driven by thrombocytopenia.
- cancer.gov
Acute myeloid leukemia is an aggressive hematologic malignancy characterized by the clonal proliferation and accumulation of immature myeloid precursors, or myeloblasts, within the bone marrow and peripheral blood
- nih.gov
Acute myeloid leukemia is an aggressive hematologic malignancy characterized by the clonal proliferation and accumulation of immature myeloid precursors, or myeloblasts, within the bone marrow and peripheral blood Pathophysiologically, the infiltration of leukemic blasts disrupts normal hematopoiesis, leading to severe bone marrow failure marked by cytopenias Consequently, patients frequently present with debilitating fatigue due to anemia, life-threatening infections secondary to neutropenia, a...
- nih.gov
Acute myeloid leukemia is an aggressive hematologic malignancy characterized by the clonal proliferation and accumulation of immature myeloid precursors, or myeloblasts, within the bone marrow and peripheral blood Pathophysiologically, the infiltration of leukemic blasts disrupts normal hematopoiesis, leading to severe bone marrow failure marked by cytopenias
- aacr.org
This rapid malignant expansion primarily affects the hematopoietic system in adults, although it can manifest across all age groups
- medlineplus.gov
This rapid malignant expansion primarily affects the hematopoietic system in adults, although it can manifest across all age groups
- medlineplus.gov
Consequently, patients frequently present with debilitating fatigue due to anemia, life-threatening infections secondary to neutropenia, and spontaneous bruising or hemorrhage driven by thrombocytopenia
Personalize your experience
Follow Acute myeloid leukemia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.